Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
IAP-0971 by Sunho (China) Biopharmaceutical for Head And Neck Squamous Cell Carcinoma (HNSC): Likelihood of Approval
IAP-0971 is under clinical development by Sunho (China) Biopharmaceutical and currently in Phase II for Head And Neck Squamous Cell...
IAP-0971 by Sunho (China) Biopharmaceutical for Liver Cancer: Likelihood of Approval
IAP-0971 is under clinical development by Sunho (China) Biopharmaceutical and currently in Phase II for Liver Cancer. According to GlobalData,...
IAP-0971 by Sunho (China) Biopharmaceutical for Cervical Cancer: Likelihood of Approval
IAP-0971 is under clinical development by Sunho (China) Biopharmaceutical and currently in Phase II for Cervical Cancer. According to GlobalData,...
IAP-0971 by Sunho (China) Biopharmaceutical for Lung Cancer: Likelihood of Approval
IAP-0971 is under clinical development by Sunho (China) Biopharmaceutical and currently in Phase II for Lung Cancer. According to GlobalData,...
IAP-0971 by Sunho (China) Biopharmaceutical for Solid Tumor: Likelihood of Approval
IAP-0971 is under clinical development by Sunho (China) Biopharmaceutical and currently in Phase II for Solid Tumor. According to GlobalData,...
IAP-0971 by Sunho (China) Biopharmaceutical for Non-Hodgkin Lymphoma: Likelihood of Approval
IAP-0971 is under clinical development by Sunho (China) Biopharmaceutical and currently in Phase II for Non-Hodgkin Lymphoma. According to GlobalData,...